Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for ...

Recently published Schizophrenia Market Insights report includes a comprehensive understanding of current treatment practices, emerging schizophrenia drugs, market share of individual therapies, and ...

AmyriAD Therapeutics B.V. ("AmyriAD"), a clinical-stage biopharmaceutical company focused on cognition in central nervous system disorders, today announced the acquisition of Recognify Life Sciences, ...

Phase 3 randomized-withdrawal data in pediatrics indicated relapse in 41.9% continuing ecopipam versus 68.1% on placebo, a 53% relative relapse-risk reduction (HR, 0.50; P = .008). New analyses from ...

Minimal Symptom Expression (MSE) is defined as a Myasthenia Gravis Activities of Daily Living (MG-ADL) score of 0 or 1, a definition increasingly recognized and applied in MG research and clinical ...

What if your dizziness, racing heart, brain fog, fatigue, anxiety, or digestive issues weren’t separate problems at all? What if they were all connected by one underlying dysfunction that most people ...

Many parents walking the difficult journey with an LGBT-identified child feel burdened by guilt, shame, regret, confusion, or fear. Some are estranged from their children. Others are trying to ...

The approval of medicines called second-generation antipsychotics has allowed bipolar I and other associated conditions to be treated. A person with bipolar I disorder can go through various mood ...

Most of my patients first come to see me in states of extreme confusion, frustration, and exasperation. They have commonly already seen a number of different doctors—generalists and specialists ...

Background: Social determinants of health —including socioeconomic status, race and ethnicity, and access to care—affect health outcomes and contribute to disparities in disease burden and treatment.